Oncological rehabilitation program to promote physical activity in cancer patients
Evaluation of an Oncological Rehabilitation Program as Part of the Promotion of Therapeutic Physical Activity in Adults Cancer Patients
This study is testing a 12-week exercise program to see if it helps cancer patients feel better and improve their quality of life after treatment.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 250 (estimated) |
| Ages | 18 Years to 80 Years |
| Sex | All |
| Sponsor | Luzerner Kantonsspital Academic / other |
| Locations | 1 site (Lucerne, Canton of Lucerne) |
| Trial ID | NCT06945757 on ClinicalTrials.gov |
What this trial studies
This study evaluates a 12-week rehabilitation program designed for adults who are currently undergoing or have recently completed cancer treatment. The program focuses on exercise-based interventions, including resistance and aerobic training, to improve the quality of life for cancer survivors. It aims to assess the feasibility, acceptability, and effectiveness of these physical activities, along with cognitive and psychological support, in addressing residual deficits such as fatigue and depression. Participants will engage in the program twice a week to monitor their progress and outcomes.
Who should consider this trial
Good fit: Ideal candidates include adults aged 18 to 80 with a history of malignancy who are starting, currently undergoing, or have recently completed cancer treatment.
Not a fit: Patients with major therapeutic toxicities that prevent participation or those lacking decisional capacity may not benefit from this program.
Why it matters
Potential benefit: If successful, this program could significantly enhance the quality of life and physical well-being of cancer survivors.
How similar studies have performed: Previous studies have shown that exercise-based rehabilitation can effectively improve outcomes for cancer survivors, indicating a promising approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Male or female patients, with an history of malignancy, who are going to start, are currently undergoing primary cancer treatment or just ended their oncological treatment, independent of cancer type. * Age between 18 and 80 years. * Available 2 days per week all along the program duration. Exclusion Criteria: * Major foreseeable risk of impossibility to participate in the session due to therapeutic toxicities or other reasons that may lead to a sustainable lack of compliance incompatible with the continuation of the program. * Patients not having a full decisional capacity * Patients not able to maintain a satisfactory professional or personal aptitude during the program.
Where this trial is running
Lucerne, Canton of Lucerne
- Luzerner Kantonsspital — Lucerne, Canton of Lucerne, Switzerland (Recruiting)
Study contacts
- Study coordinator: Andrea O Fontana, MD PhD
- Email: andrea.fontana@luks.ch
- Phone: +41795472905
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.